PBM Reform: Vertical Integration, Specialty Drug Tracking Among Differences In House v. Senate Bills

 
• By Sarah Karlin-Smith

House Energy and Commerce Committee cleared a PBM bill that seems to contain more transparency loopholes and makes more limited policy tweaks to the drug supply chain middleman than the Senate HELP Committee’s bill, but the House-side legislation would pull back the curtain on specialty-drug reimbursement in a way the Senate version does not.

view of NYC intersection from above
Senate HELP’s PBM transparency bill will likely yield more insights on PBM’s vertical integration than the House E&C’s. • Source: Shutterstock

More from Pricing Debate

More from Market Access